Rare diseases
Investigational molecules
Locations
Back to the Netherlands616 clinical trials in Utrecht, The Netherlands across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study of Pembrolizumab, Lenvatinib, and Belzutifan for Patients with Renal Cell Carcinoma
The NetherlandsStudy on Tisagenlecleucel for High-Risk B-Cell Acute Lymphoblastic Leukemia in Pediatric and Young Adult Patients with Minimal Residual Disease
The NetherlandsStudy of Daratumumab with Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Eligible for High-Dose Therapy
The NetherlandsLong-term Safety Study of Etranacogene Dezaparvovec in Adult Men with Hemophilia B
The NetherlandsLong-term Study of Zanubrutinib for Patients with B-cell Blood Cancer
The NetherlandsStudy to Identify Unknown Primary Cancer Using [18F]-AlF-FAPI-74 PET-CT for Patients with Carcinoma of Unknown Primary
The NetherlandsStudy of SAR443579 Infusion for Adults and Children with Relapsed or Refractory Acute Myeloid Leukemia, B-Cell Acute Lymphoblastic Leukemia, HR-MDS, or BPDCN
The NetherlandsStudy on Vericiguat for Children with Heart Failure from Left Ventricular Systolic Dysfunction
The NetherlandsStudy on RYZ101 for Patients with Advanced Gastroenteropancreatic Neuroendocrine Tumors After Previous Treatment
The NetherlandsStudy on Finerenone for Children with Chronic Kidney Disease and Proteinuria Using ACEI or ARB
The NetherlandsStudy Comparing Ciltacabtagene Autoleucel with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed and Lenalidomide-Refractory Multiple Myeloma
The NetherlandsStudy of Belzutifan with Lenvatinib versus Cabozantinib in Adults with Advanced Renal Cell Carcinoma Who Have Previously Received Anti-PD-1/L1 Treatment
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on TTR amyloidosis and heart disease treatments, investigating new therapeutic approaches for cardiac conditions. Clinical trials evaluate novel medications for improving patient mobility and cardiac function.
Research aims to enhance quality of life for patients with hereditary and wild-type ATTR cardiomyopathy.
Comprehensive studies in gastric cancer, bladder cancer, and neuroblastoma, exploring innovative treatment combinations and diagnostic methods.
Advanced trials combining established treatments with novel approaches to improve patient outcomes.
Groundbreaking research in Amyotrophic Lateral Sclerosis and chronic inflammatory conditions, focusing on innovative treatments and disease modification strategies.
Studies aim to develop effective treatments for rare and challenging neurological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
